Prospective Randomised study on imiquimod 5% cream as pretreatment of Mohs micrographic surgery for primary large nodular basal cell carcinoma in the face to reduce the post-Mohs defect size.
Phase of Trial: Phase IV
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Imiquimod (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 03 Mar 2012 Results published in the British Journal of Dermatology.
- 16 Sep 2009 New trial record